Deep and Dynamic Metabolic and Structural Imaging in Living Tissues
Authors:
Kunzan Liu,
Honghao Cao,
Kasey Shashaty,
Li-Yu Yu,
Sarah Spitz,
Francesca Michela Pramotton,
Zhengpeng Wan,
Ellen L. Kan,
Erin N. Tevonian,
Manuel Levy,
Eva Lendaro,
Roger D. Kamm,
Linda G. Griffith,
Fan Wang,
Tong Qiu,
Sixian You
Abstract:
Label-free imaging through two-photon autofluorescence (2PAF) of NAD(P)H allows for non-destructive and high-resolution visualization of cellular activities in living systems. However, its application to thick tissues and organoids has been restricted by its limited penetration depth within 300 $μ$m, largely due to tissue scattering at the typical excitation wavelength (~750 nm) required for NAD(P…
▽ More
Label-free imaging through two-photon autofluorescence (2PAF) of NAD(P)H allows for non-destructive and high-resolution visualization of cellular activities in living systems. However, its application to thick tissues and organoids has been restricted by its limited penetration depth within 300 $μ$m, largely due to tissue scattering at the typical excitation wavelength (~750 nm) required for NAD(P)H. Here, we demonstrate that the imaging depth for NAD(P)H can be extended to over 700 $μ$m in living engineered human multicellular microtissues by adopting multimode fiber (MMF)-based low-repetition-rate high-peak-power three-photon (3P) excitation of NAD(P)H at 1100 nm. This is achieved by having over 0.5 MW peak power at the band of 1100$\pm$25 nm through adaptively modulating multimodal nonlinear pulse propagation with a compact fiber shaper. Moreover, the 8-fold increase in pulse energy at 1100 nm enables faster imaging of monocyte behaviors in the living multicellular models. These results represent a significant advance for deep and dynamic metabolic and structural imaging of intact living biosystems. The modular design (MMF with a slip-on fiber shaper) is anticipated to allow wide adoption of this methodology for demanding in vivo and in vitro imaging applications, including cancer research, autoimmune diseases, and tissue engineering.
△ Less
Submitted 18 April, 2024;
originally announced April 2024.
